986 Pharmacy vs R3VIVE
Franchise Comparison 2026
Both 986 Pharmacy and R3VIVE are healthcare franchises. 986 Pharmacy requires an investment of $280K – $671K while R3VIVE requires $262K – $669K. Neither 986 Pharmacy nor R3VIVE makes a financial performance representation in Item 19 of its FDD — a voluntary item under the FTC Franchise Rule — so the two cannot be compared on disclosed unit revenue. FranchiseVerdict rates 986 Pharmacy B (Above average) and R3VIVE B (Above average).
| Metric | 986 Pharmacy | R3VIVE |
|---|---|---|
| Verdict Grade | BAbove average | BAbove average |
| Investment Range | $280K – $671K | $262K – $669K |
| Franchise Fee | $75K | $75K |
| Royalty Rate | Continuing License Fee: $1,575/month for first 12 months, then $2,100/month for remainder of term (Item 6 lists $1,650 for first 21 days then $2,100; footnote 2 states $1,575 for first 12 months then $2,100). May increase up to 5% annually. No percentage-of-sales royalty. | 6.0% |
| Average Revenue (Item 19) | N/ANo Item 19 representation | N/ANo Item 19 representation |
| SBA Charge-Off Rate | Limited data | N/A |
| Total Units | 44 | 10 |
| Unit Growth (YoY) | +14 units | +2 units |
| Year Began Franchising | 2018 | 2020 |
| FDD Year | 2025 | 2022 |
Investment Range
$280K – $671K
$262K – $669K
Franchise Fee
$75K
$75K
Royalty Rate
Continuing License Fee: $1,575/month for first 12 months, then $2,100/month for remainder of term (Item 6 lists $1,650 for first 21 days then $2,100; footnote 2 states $1,575 for first 12 months then $2,100). May increase up to 5% annually. No percentage-of-sales royalty.
6.0%
Average Revenue (Item 19)
N/ANo Item 19 representation
N/ANo Item 19 representation
SBA Charge-Off Rate
Limited data
N/A
Total Units
44
10
Unit Growth (YoY)
+14 units
+2 units
Year Began Franchising
2018
2020
FDD Year
2025
2022